Microtubular proteolysis in focal cerebral ischemia.
Calpain, a neutral protease activated by calcium, may promote microtubular proteolysis in ischemic brain. We tested this hypothesis in an animal model of focal cerebral ischemia without reperfusion. The earliest sign of tissue injury was observed after no more than 15 min of ischemia, with coiling of apical dendrites immunolabeled to show microtubule-associated protein 2 (MAP2). After 6 h of ischemia, MAP2 immunoreactivity was markedly diminished in the infarct zone. Quantitative Western analysis demonstrated that MAP2 was almost unmeasurable after 24 h of ischemia. An increase in calpain activity, shown by an antibody recognizing calpain-cleaved spectrin fragments, paralleled the loss of MAP2 immunostaining. Double-labeled immunofluorescent studies showed that intraneuronal calpain activity preceded evidence of MAP2 proteolysis. Perikaryal immunolabeling of tau protein became increasingly prominent between 1 and 6 h in neurons located within the transition zone between ischemic and unaffected tissue. Western blot experiments confirmed that dephosphorylation of tau protein occurred during 24 h of ischemia, but was not associated with significant loss of tau antigen. We conclude that focal cerebral ischemia is associated with early microtubular proteolysis caused by calpain.
Sanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington 40536-0230, USA.
L C
LC
Pettigrew
M L
ML
Holtz
S D
SD
Craddock
S L
SL
Minger
N
N
Hall
J W
JW
Geddes
D000818:Animals; D002545:Brain Ischemia / Q000378:metabolism / Q000473:pathology*; D007150:Immunohistochemistry; D008297:Male; D008869:Microtubule-Associated Proteins / Q000032:analysis*; D008870:Microtubules / Q000473:pathology*; D051381:Rats; D011918:Rats, Inbred SHR
D008869:Microtubule-Associated Proteins